Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Metformin × Thoracic × Clear all

Phase

Status

Terminated 8 Completed 6 Unknown 4 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 CNS 4 Other solid neoplasm 3 Gastrointestinal 3 Dermatologic 3 Sarcoma 2 Other hematologic neoplasm 2 Other 2 Head & Neck 2 Gynecologic 2 Breast 2 Thoracic 1 Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 186 pembrolizumab 159 Pemetrexed 134 Cisplatin 101 Drug Therapy 68 Paclitaxel 61 osimertinib 54 Radiotherapy 51 Nivolumab 51 Magnetic Resonance Spectroscopy 49 Specimen Handling 47 durvalumab 46 Docetaxel 45 atezolizumab 43 Etoposide 42 Bevacizumab 39 tislelizumab 34 Blood Specimen Collection 33 Radiosurgery 30 Gemcitabine 27 130-nm albumin-bound paclitaxel 27 Immunotherapy 26 cemiplimab 24 Immune Checkpoint Inhibitors 24 Injections 21 aflutinib 20 Cetuximab 19 Surgical Procedures, Operative 17 Standard of Care 17 Biopsy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05445791 2026-04-09

METLUNG

Instituto Nacional de Cancerologia de Mexico

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡